Latest Biotech News

Innovative environmental solutions show promise in mitigating climate impacts. Dairy digesters in California effectively capture and reuse methane, reducing emissions by about 80%. In renewable...

Cancer research progresses with insights into tumor plasticity, glycosaminoglycan-mediated lipoprotein uptake protecting tumors from ferroptosis, and novel gene therapy strategies targeting rare...

BioNTech confirmed the acquisition of CureVac in a $1.25 billion all-stock deal that resolves ongoing mRNA patent litigation while enhancing its oncology pipeline. The agreement includes CureVac’s...

A pioneering brain-computer interface enabled a man with ALS to speak and sing naturally by synthesizing voice nearly instantaneously from neural signals, restoring expressive communication with...

After discontinuing multiple clinical-stage programs due to poor efficacy, ADC Therapeutics is closing its UK research site and laying off 30% of staff to focus efforts on approved therapies and...

BioNTech has struck an all-stock agreement to acquire CureVac, a fellow German mRNA vaccine and cancer immunotherapy developer, for approximately $1.25 billion. The deal settles ongoing patent...

The FDA approved UroGen Pharma’s intravesical hydrogel treatment, Zusduri (formerly UGN-102), for recurrent low-grade, intermediate-risk non-muscle invasive bladder cancer despite a narrowly...

Nuvation Bio received FDA approval for Ibtrozi (taletrectinib), a next-generation oral inhibitor targeting ROS1-positive non-small cell lung cancer (NSCLC), a disease subset with limited existing...

Innovative AI applications are reshaping drug development and biologics characterization. Infinimmune launched GLIMPSE-1, a protein language model trained using human antibody sequences, to...

Researchers have developed a brain-computer interface (BCI) capable of nearly instantaneous voice synthesis from neural signals with natural speech features like intonation and singing. Implanted...

A new computational platform rapidly generates complex vasculature trees at organ scale within minutes, a 230-fold speed increase over previous methods. Developed by Sexton and colleagues, it...

An interdisciplinary team led by Harvard’s Wyss Institute used AI-driven dynamic molecular modeling to develop bemcentinib, an FDA-approved oral drug repurposed to target coronaviruses...

The Wellcome Sanger Institute, Helmholtz Munich, and Parse Biosciences announced a collaborative project to build a large single-cell atlas of cancer plasticity. By analyzing hundreds of millions...

Multiple studies advance understanding of Parkinson's disease biology and diagnostics. Research into genetic variant severity and polygenic backgrounds informs penetrance and progression risk for...

Multiple studies address energy, environmental, and climate challenges. Research reveals how green energy and steel imports reduce Europe’s net-zero infrastructure requirements. New zinc–iodine...

BioNTech’s $1.25 billion acquisition of CureVac resolves ongoing mRNA patent disputes and strengthens its oncology pipeline. The all-stock deal provides BioNTech with CureVac’s cutting-edge...

Researchers have created a computational design platform that rapidly generates complex, organ-scale vasculature trees enabling improved perfusion for 3D bioprinted tissues. This marks a...

ADC Therapeutics announced closure of its UK R&D site, layoffs cutting 30% of staff, and discontinuation of several preclinical oncology programs following clinical failures. The restructuring...

BioNTech’s acquisition of CureVac for approximately $1.25 billion closes lingering mRNA patent disputes and enhances its mRNA cancer immunotherapy capabilities. The all-stock deal values CureVac...

The FDA expanded eligibility for Moderna's mRESVIA RSV vaccine to include at-risk adults aged 18 and older shortly after approving its updated COVID-19 vaccine. Meanwhile, notable changes in US...